Literature DB >> 1865133

Direct tolerance induction in mature B lymphocytes may resemble clonal anergy phenomenon.

M Aldo-Benson1, L Pratt.   

Abstract

Several mechanisms have been postulated for direct induction of B-cell tolerance in mature B cells, such as the Bretscher and Cohn [5] hypothesis which states that an antigenic signal to B cells without the 'second signal' provided by T cells or lymphokines produces unresponsiveness. A second explanation is that tolerogens which cross-link immunoglobulin and Fc receptors abort the biochemical activation of the B cell via the phosphatidyl inositol pathway. Results of our studies are not consistent with either of these hypotheses. We speculated that DNP-MGG induces immunoglobulin receptor capping and internalization in mature B cells, but a suppressive signal is given to the B cell when DNP-MGG is present at the time of antigen receptor reexpression in a fashion similar to clonal anergy. The studies reported here test this hypothesis as a possible additional mechanism of direct B-cell tolerance. When pure DNP-specific B cells were incubated for 6 h with DNP-MGG in the presence of lymphokine-rich EL-4 supernatant, an immune response was induced; but 48 h preincubation with DNP-MGG in the presence of lymphokines induced tolerance. If B-cell cultures were preincubated with DNP-MGG for 6 h followed by a 24-hour incubation without conjugate and DNP-MGG was then added for the third preincubation period of 18 h (at a time when receptors are being reexpressed), tolerance was induced. Substitution of DNP-Ficoll antigen for DNP-MGG in either the first or third time period did not result in tolerance induction but substituting DNP-KLH during either of these two periods did result in tolerance.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1865133     DOI: 10.1007/bf02918169

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  22 in total

1.  Activation of human B cells and inhibition of their terminal differentiation by monoclonal anti-mu antibodies.

Authors:  S Maruyama; H Kubagawa; M D Cooper
Journal:  J Immunol       Date:  1985-07       Impact factor: 5.422

Review 2.  Cellular mechanisms of immunologic tolerance.

Authors:  G J Nossal
Journal:  Annu Rev Immunol       Date:  1983       Impact factor: 28.527

3.  A theory of self-nonself discrimination.

Authors:  P Bretscher; M Cohn
Journal:  Science       Date:  1970-09-11       Impact factor: 47.728

4.  Tolerance and immunity in antigen-specific B-lymphocyte lines: early receptor binding of either antigen or tolerogen initiates an immune response.

Authors:  M A Aldo-Benson; L M Scheiderer
Journal:  Cell Immunol       Date:  1985-09       Impact factor: 4.868

5.  The role of cytoplasmic free calcium concentration in B-cell tolerance.

Authors:  M Aldo-Benson; B P Tsao
Journal:  Cell Immunol       Date:  1987-09       Impact factor: 4.868

6.  2,4-Dinitrophenyl (DNP)-specific continuous B cell lines as a model system for studying B cell activation and tolerance.

Authors:  M Aldo-Benson; L Scheiderer; F E Dwulet
Journal:  Eur J Immunol       Date:  1986-01       Impact factor: 5.532

7.  Ligand-induced movement of lymphocyte membrane macromolecules. I. Analysis by immunofluorescence and ultrastructural radioautography.

Authors:  E R Unanue; W D Perkins; M J Karnovsky
Journal:  J Exp Med       Date:  1972-10-01       Impact factor: 14.307

8.  Long-term growth of lines of murine dinitrophenyl-specific B lymphocytes in vitro.

Authors:  M Aldo-Benson; L Scheiderer
Journal:  J Exp Med       Date:  1983-01-01       Impact factor: 14.307

9.  Lymphoma models for B cell activation and tolerance. III. Cell cycle dependence for negative signalling of WEHI-231 B lymphoma cells by anti-mu.

Authors:  D W Scott; D Livnat; C A Pennell; P Keng
Journal:  J Exp Med       Date:  1986-07-01       Impact factor: 14.307

10.  Nonantigenicity and immunologic tolerance: the role of the carrier in the induction of tolerance to the hapten.

Authors:  D T Golan; Y Borel
Journal:  J Exp Med       Date:  1971-10-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.